Nocopi Technologies, Inc. is a nanocap company specializing
in document security and product authentication. The company was founded by in
1983 and is based in King of Prussia, PA – just outside of Philadelphia.
The company was initially engaged in the authentication
space, developing copy-resistant papers which would inhibit the reproduction of
sensitive documents on a standard office copier. From there, the company moved
into creating specialty ink technologies which would hamper reproduction or
counterfeiting efforts. More recently, the company has developed specialty
reactive inks for use in the educational and entertainment markets.
Of note to parents (myself included) is the “mess-free” ink
which is commonly found in coloring books and activity books. This ink allows
the child to draw freely with a marker/pen and the color or design only shows
up on parts of the paper which have been printed with Nocopi’s ink. This
toy/entertainment market opportunity is huge and is driving new revenue for the
company. Other applications include “Magic Ink”, which is used in coloring/activity
books marketed by leading child-focused publishers, and “Rub-it & Color”,
which allows the user to scratch a paper’s surface and display a variety of
colors.
Additionally, around 25% of revenues are derived from
pharmaceutical and beauty companies that use Nocopi’s technology to apply
secret or hidden product markings to manage and monitor product authenticity. Beyond
these uses, the company is still providing authentication technologies to
Fortune 500 companies.
Nocopi is led by Dr. Michael Feinstein (CEO) and Terry
Stovold (COO). Additionally, the company uses a consulting CFO for the time
being. Dr. Feinstein is in the process of winding down his medical practice in
order to devote more time to Nocopi and lead its recent investor relations and marketing
effort.
The company’s primary sources of revenue include: licensing the
use of its technology, royalties, product sales, and fees for technical
services. Over the last several years, management has been focused on
establishing a strong financial base and building brand awareness in the
marketplace – this effort seems to be paying off, which should be obvious by
looking at the balance sheet. From 4Q2014 to 4Q2018, the company’s cash
position grew over 1300%, from $30K to $400K, while liabilities decreased
almost 34%, from $830K to $550K. Accumulated Deficit for shareholder has been
decreased over 17%, from $13.43MM to $11.06MM.
Turning to the income statement, we see more encouraging
signs. Revenues during this period have grown from $920k to $3.34MM*, an increase
of over 360%. Gross profits grew by over 460%, from $600k (65% gross margins) to
$2.78MM (83% gross margins), indicating that the company has become more
efficient in how it generates revenue. This is supported by operating expenses,
which grew by only 65% from $890K to $1.47MM. Bottom line net income grew from $10K
to $1.66MM, an astounding 16,600% increase. One other item to keep in mind is
that as of 12/31/2018 the company has approximately $2.5MM net operating loss
carryforwards.
*Note that due to the nature of its licensing agreements, Nocopi
had to recognize the present value of a four-year licensing agreement which was
signed in 2018, meaning that 2018 revenues include $1.5MM from this agreement.
This licensing agreement will pay out a minimum of $100K/quarter for four
years, beginning in 3Q2019 – so cash will be coming in the door but it will be “hidden”
when looking at the income statement.
Taking a look at 2019, the first three quarters of the year
show continued strength: if we back out the $1.5MM in licensing revenue discussed
above, 2018 revenues were $1.84MM. Through 3Q2019, revenues are $1.57MM, with a
realistic year-end estimate being $2.0MM – $2.5MM. Net income through three
quarters is $440K, likely to end the year around $600K – $750K. This would lead
to EPS of somewhere around $.01 – $.013, a meaningful increase from adjusted
2018 EPS.
The balance sheet through the first three quarters of 2019
has also shown signs of strength. The company ended 2018 with $400K in cash,
and as of 9/30/2019 has approximately $800K in cash. Liabilities have grown
somewhat from $550K to $710K, due largely to an increase in accrued expenses
and other liabilities. Still, the company has current assets of $1.87MM and
total liabilities of only $710K. Perhaps a better way to look at this company’s
balance sheet is to say that Nocopi has liquid assets of $1.63MM and current
liabilities of only $420K, giving it a quick ratio of 3.88. The company had a
tangible book value per share of $.041 as of 9/30/2019. The company is building
a strong balance sheet and is management has shown a commitment to turning this
company into one that will last.
During this period of growth, management made a concerted
effort to reduce fixed costs to a reasonable and sustainable level. While this
has contributed to the margin growth, the truth is that this business does not
have huge operating expenses so there is only so much expense cutting that can be
done. This means that with costs under control, it is incumbent upon management
to grow top-line revenue, i.e. find more meaningful licensing opportunities. To
this end, management has been able to grow the product base to include popular
franchises from names such as Disney, Marvel, Nickelodeon, DreamWorks, etc. While
this does pose a risk to the company (inability to generate new licensing opportunities
means no new revenue coming in), I believe the opportunity and potential for
Nocopi far outweigh the risks. Licensing and royalty revenue is cheap, it does
not carry significant costs and therefore the margins on this type of revenue
are huge. Focusing on licensing and royalty revenue while also maintain a
presence in the retail/security/authentication market is the way forward for Nocopi
and I’m glad to see management moving in this direction.
Currently, the company is trading for $.065/share, giving it a market capitalization of $3.9MM. The company has seen its share price increase since releasing Q3 numbers in November 2019. At a project 2019 EPS of $.011/share, it is currently trading at a P/E of 6. As the company grows revenue and further solidifies its balance sheet, I think a price target in the $.12 – $.20 range is reasonable. Will it get there? I’m not sure. But I believe management is making the right moves regarding generating revenue and solidifying the balance sheet. I’d like to see them increase the number of licensing agreements and maybe even types of products that are offered. Spending a little more on R&D wouldn’t bother me, but overall I think they are headed in the right direction. I’m happy to be a shareholder and will be watching this company with a keen eye for the next few years.
Disclosure: It should be obvious but I am long Nocopi Technologies, Inc.